Form 4: Cadre Holdings CEO Warren B. Kanders Sells 100,000 Shares Under Pre-Arranged Plan
Insider Transaction Report
Cadre Holdings, Inc. CEO and Chairman Warren B. Kanders reported the sale of 100,000 shares of common stock over two days in May 2025, executed under a Rule 10b5-1 trading plan.
Summary
- Warren B. Kanders, the CEO, Chairman, Director, and 10% Owner of Cadre Holdings, Inc. (CDRE), reported the sale of 100,000 shares of the company's common stock.
- On May 22, 2025, Mr. Kanders sold 50,000 shares at a weighted average price of $33.19 per share, with prices ranging from $33.11 to $33.34.
- On May 23, 2025, an additional 50,000 shares were sold at a weighted average price of $32.65 per share, with prices ranging from $32.49 to $32.97.
- These transactions were conducted pursuant to a Rule 10b5-1(c) trading plan, indicating they were pre-scheduled.
- Following these sales, Mr. Kanders' beneficial ownership, primarily through Kanders SAF, LLC, decreased to 10,616,192 shares indirectly held by Kanders SAF, LLC, 45,584 shares held directly, 1,305,650 shares indirectly held by Warren B. Kanders Roth IRA, and 23,450 shares indirectly held by Allison Kanders Roth IRA (spouse).
- The total beneficial ownership after these transactions is approximately 11,990,876 shares.
Sentiment
Score: 5
Explanation: The sentiment is neutral to slightly negative. While insider selling can be perceived negatively, the disclosure that it was conducted under a pre-arranged Rule 10b5-1 plan mitigates some of the negative implications, suggesting it's a planned diversification rather than a reaction to adverse company news.
Negatives
- The sale of 100,000 shares by a key insider like the CEO and Chairman, even if pre-planned, can be perceived negatively by investors as it reduces management's direct equity stake in the company.
Risks
- Investor sentiment may be negatively impacted by the insider selling, potentially leading to short-term downward pressure on the stock price.
- While executed under a 10b5-1 plan, significant insider sales can sometimes raise questions about management's long-term confidence in the company's future prospects, even if not intended.
Future Outlook
This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future financial performance or strategic outlook.
Management Comments
- The Reporting Person disclaims beneficial ownership of the securities described in this statement, except to the extent of his pecuniary interest in such securities.
Industry Context
This filing is a standard insider transaction report and does not provide specific insights into broader industry trends or competitive landscape. Insider sales are common across industries, often for diversification or liquidity purposes.
Stakeholder Impact
- Shareholders: May interpret the insider selling as a signal, potentially influencing their investment decisions, although the 10b5-1 plan context should be considered.
Key Dates
| Date | Description |
|---|---|
| 05/22/2025 | Date of first reported transaction (sale of 50,000 shares). |
| 05/23/2025 | Date of second reported transaction (sale of 50,000 shares). |
| 05/27/2025 | Date the Form 4 filing was signed. |
Recommendation
holdKeywords
Cadre Holdings, CDRE, Warren B. Kanders, Insider Trading, Stock Sale, Form 4, Rule 10b5-1, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.